US Stock Futures and Bond Yields Decline After Reports of Updated Russian Nuclear Doctrine
Standard Chartered CEO Apologizes for Controversial Lower Value Human Capital Remark
Arsenals Brand Power How Cultural Reach Sustains Commercial Value Despite OnField Struggles
The Mandalorian and Grogu Draws Strong Early Praise Could Reinvigorate Star Wars Franchise
General Motors Introduces AllElectric Cadillac Vistiq with 300Mile Range
Oil Supply Crunch Expected Later Than Initially Anticipated
Recursion Pharmaceuticals Q1 2026 Earnings EPS Beat Amidst Pipeline Development
WaFd Inc WAFD Q1 2026 Earnings Earnings Beat Surprises Markets Yet Shares Slip
First Solar FSLR Q1 2026 Earnings EPS Surges Past Estimates as Operational Strength Drives Confidence
SCVL Q1 2026 Earnings Modest Miss on EPS Amid Challenging Retail Environment
NextDecade Corporation Q1 2026 Earnings EPS Surprise Beats Estimates Amid PreRevenue Phase
American Financial Group Q1 2026 Earnings EPS Misses Estimates Amid Premium Growth Headwinds
SmithMidland SMID Gains 33 as Price Nears Key Resistance Level
inTest Corporation INTT Holds Steady Near 1829 as Semiconductor Sector Faces Crosscurrents
CRA International CRAI Modestly Advances Above Key Support as Trading Remains Measured
Anixa Biosciences ANIX Slides 215 as Biotech Sector Headwinds Return
Urban Edge Properties UE Posts Slight Gain as Stock Holds Above Support Level
Tony Blairs Economic Diagnosis Praised but AIFocused Prescription Questioned by Analysts
ClearSign Technologies CLIR Q1 2026 Earnings WiderThanExpected Loss Stalls Recovery Hopes
Washington Trust Bancorp WASH Holds Near Support as Slight Dip Tests Key Levels
Context Therapeutics Inc CNTX Shows Modest Gains Near Key Resistance Level
Fulcrum Therapeutics FULC Hovers Near Support After Marginal Uptick
Templeton Dragon Fund TDF Holds Near 1118 in Tight Range Minor Gain Signals Consolidation
Aclaris Therapeutics ACRS Gains 244 as Buyers Defend Key Support Zone
Ioneer Ltd IONR Rises 218 as Shares Approach Key Resistance Level
SLM Corporation Rallies Testing Resistance Near 2326
Entrada Therapeutics TRDA Edges Lower Amid Light Trading Key Support at 617 in Focus